Skip to main content
Premium Trial:

Request an Annual Quote

Interleukin Genetics Moves to New Pink Sheets Service

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Interleukin Genetics has moved its stock from the New York Stock Exchange Amex to the Pink Quote’s OTCQB, a new quotation service run by Pink OTC Markets, as of today.

Stock in the Waltham, Mass.-based genetic testing company, which is now listed under the symbol ILIU.PK, was listed as trading this morning at $.25 a share, down 40 percent from its Friday close.

Interleukin received a delisting notice from the New York Stock Exchange's Amex in June.

The OTCQB was introduced recently to distinguish over-the counter securities that are registered and are reporting with the US Securities and Exchange Commission or a banking or insurance regulator.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.